Skip to content
Home
About us
Insights
Stocks
Compliance
Special Services
Contact
Language
EN
BR
EN
EN
BR
Tag:
Brazil healthcare
Insights
Hapvida Debt Repricing Deepens as BTG Flags Rising Leverage Risks
20 de March de 2026
Behind the Lines
Hapvida: Costly cure
19 de March de 2026
Insights
Novo Nordisk Offers Free Wegovy Starter Dose as Semaglutide Patent Expires in Brazill
2 de March de 2026
Insights
Lula Unveils R$1 Billion Health Push at Butantan to Scale Vaccines and Serums
8 de February de 2026
Insights
Oncoclínicas Confirms It Hired Consultant to Search for New CEO
9 de January de 2026
Insights
Brazil’s Healthcare Heads Into 2026 With Rede D’Or as a Clear Winner and Hapvida Under Stress
29 de December de 2025
Insights
Rede D’Or Joins Federal Program to Expand Specialized Surgeries for Brazil’s Public Health System
22 de December de 2025
Insights
Oncoclínicas Moves Toward Extraordinary Meeting That Could Oust Entire Board
11 de December de 2025
Insights
Latache Moves to Oust Oncoclínicas Board in Full Overhaul Push
26 de November de 2025
Insights
Hapvida Defends Verticalization as Shares Drop Over 40% After Margin-Hit Quarter
13 de November de 2025
←
Previous Page
1
2
3
